Efficacy of zoledronic acid for the elimination of disseminated tumor cells in a clinically relevant, spontaneously metastatic prostate cancer xenograft model
Bone · 2023-06 · 171 · 116741
DOI: 10.1016/j.bone.2023.116741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2023-06. Verfasst von Lukas Clemens Böckelmann und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hambu…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Bone Density Conservation Agents, Bone Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Oncology, Hematology and…
- Institute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Anatomy and Experimental Morphology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Anatomy I, Cancer Center…
- Department of Osteology and Biomechanics, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Trauma Surgery and Orthopedics, University Medical Center Hamburg-…
- Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Böckelmann, L. C., Freytag, V., Ahlers, A. K., Maar, H., Gosau, T., Baranowsky, A., Schmitz, R., Pantel, K., Schumacher, U., Haider, M. T., & Lange, T. (2023). Efficacy of zoledronic acid for the elimination of disseminated tumor cells in a clinically relevant, spontaneously metastatic prostate cancer xenograft model. Bone, 171, 116741. https://doi.org/10.1016/j.bone.2023.116741
Vancouver
Böckelmann LC, Freytag V, Ahlers AK, Maar H, Gosau T, Baranowsky A, et al. Efficacy of zoledronic acid for the elimination of disseminated tumor cells in a clinically relevant, spontaneously metastatic prostate cancer xenograft model. Bone. 2023;171:116741. doi:10.1016/j.bone.2023.116741
BibTeX
@article{Bckelmann2023,
author = {Böckelmann, Lukas Clemens and Freytag, Vera and Ahlers, Ann-Kristin and Maar, Hanna and Gosau, Tobias and Baranowsky, Anke and Schmitz, Rüdiger and Pantel, Klaus and Schumacher, Udo and Haider, Marie-Therese and Lange, Tobias},
title = {Efficacy of zoledronic acid for the elimination of disseminated tumor cells in a clinically relevant, spontaneously metastatic prostate cancer xenograft model},
journal = {Bone},
year = {2023},
volume = {171},
pages = {116741},
doi = {10.1016/j.bone.2023.116741}
}
EUVIMED